Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) and Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) for Biochemical Recurrence After Radical Prostatectomy
Medical Science Monitor · 2025
DOI: 10.12659/msm.951769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Monitor, 2025. Verfasst von Hui Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Taizhou People's Hospital Affiliated to Nanjing Medical University, Taizhou, Jiangsu, China. Hauptthemen laut MEDLINE: Receptors, Urokinase Plasminogen Activator, Prostatic Neoplasms, Neutrophils, Lymphocytes. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Taizhou People's Hospital Affiliated to Nanjing Medical University, Taizhou, Jiangsu, China.
- Medical Examination Center, Taizhou Fourth People's Hospital, Taizhou, Jiangsu, China.
Zitieren
APA
Wang, H., & Huang, C. (2025). Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) and Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) for Biochemical Recurrence After Radical Prostatectomy. Medical Science Monitor. https://doi.org/10.12659/msm.951769
Vancouver
Wang H, Huang C. Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) and Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) for Biochemical Recurrence After Radical Prostatectomy. Medical Science Monitor. 2025. doi:10.12659/msm.951769
BibTeX
@article{Wang2025,
author = {Wang, Hui and Huang, Chenxi},
title = {Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) and Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) for Biochemical Recurrence After Radical Prostatectomy},
journal = {Medical Science Monitor},
year = {2025},
doi = {10.12659/msm.951769}
}
EUVIMED